Home
E-submission
Sitemap
Contact us
ABOUT
Aims and scope
About the journal
About the society
Editorial board
Managing team
Best practice
Metrics
Contact us
ARTICLE & TOPICS
Article Category
Editorial
Review
Original article
Case report
Images of the issue
Letters to the editor
Others
Browse all articles >
TOPICS
IBD
Infection
Tumor
Endoscopy
Microbiota
Miscellaneous
Functional disorder
Browse all articles >
BROWSE ARTICLES
Current issue
All issues
Ahead-of print
Most view
Most download
Most cited
Hot topic
Funded articles
Search
Author index
EDITORIAL POLICY
Research & publication ethics
Peer review policy
Copyright & license
Others
- Data sharing policy
- Archiving policy
- Preprint policy
- Advertising policy
- CrossMark policy
FOR CONTRIBUTORS
FOR AUTHORS
Instructions to authors
Review flow
Article processing charge
Author’s checklist
Copyright transfer agreement
E-submission
FOR REVIEWERS
Instructions to reviewers
How to become a reviewer?
FOR READERS
Open access
Subscription information
TOC alerts
How to cite this journal?
Permission request
Search
Intest Res Search
CLOSE
Article category
Page Path
HOME
ARTICLE CATEGORY
Article category
Article category
Editorial (59)
Review (155)
Original article (457)
Case report (182)
Images of the issue (33)
Letters to the editor (31)
Others (116)
IBD
Vedolizumab does not increase perioperative surgical complications in patients with inflammatory bowel disease, cohort study
Vitaliy Y. Poylin, Jose Cataneo Serrato, Jonathan Pastrana Del Valle, Joseph D. Feuerstein
Intest Res.
2022;20(1):72-77.
Published online February 3, 2021
DOI:
https://doi.org/10.5217/ir.2020.00117
Cited By 8
Full text
PubReader
ePub
PDF
Maintaining infliximab induced clinical remission with azathioprine and 5-aminosalicylates in acute severe steroid-refractory ulcerative colitis has lower cost and high efficacy (MIRACLE): a multicenter study
Ramit Mahajan, Arshdeep Singh, Saurabh Kedia, Kirandeep Kaur, Vandana Midha, Pabitra Sahu, Varun Mehta, Dharmatma Singh, Namita Bansal, Khushdeep Dharni, Sandeep Kaushal, Vineet Ahuja, Ajit Sood
Intest Res.
2022;20(1):64-71.
Published online February 3, 2021
DOI:
https://doi.org/10.5217/ir.2020.00100
Cited By 9
Full text
PubReader
ePub
PDF
The dietary practices and beliefs of British South Asian people living with inflammatory bowel disease: a multicenter study from the United Kingdom
Benjamin Crooks, Ravi Misra, Naila Arebi, Klaartje Kok, Matthew J. Brookes, John McLaughlin, Jimmy K. Limdi
Intest Res.
2022;20(1):53-63.
Published online January 6, 2021
DOI:
https://doi.org/10.5217/ir.2020.00079
Cited By 8
Full text
PubReader
ePub
PDF
Supplementary Material
An integrative review of physical activity in adults with inflammatory bowel disease
Suja P Davis, Patricia B. Crane, Linda P. Bolin, Lee Ann Johnson
Intest Res.
2022;20(1):43-52.
Published online January 22, 2021
DOI:
https://doi.org/10.5217/ir.2020.00049
Cited By 8
Full text
PubReader
ePub
PDF
Supplementary Material
Microbiota
The role of microbiome in colorectal carcinogenesis and its clinical potential as a target for cancer treatment
Sang Hoon Kim, Yun Jeong Lim
Intest Res.
2022;20(1):31-42.
Published online May 21, 2021
DOI:
https://doi.org/10.5217/ir.2021.00034
Cited By 17
Full text
PubReader
ePub
PDF
IBD
Use of thiopurines in inflammatory bowel disease: an update
Arshdeep Singh, Ramit Mahajan, Saurabh Kedia, Amit Kumar Dutta, Abhinav Anand, Charles N. Bernstein, Devendra Desai, C. Ganesh Pai, Govind Makharia, Harsh Vardhan Tevethia, Joyce WY Mak, Kirandeep Kaur, Kiran Peddi, Mukesh Kumar Ranjan, Perttu Arkkila, Rakesh Kochhar, Rupa Banerjee, Saroj Kant Sinha, Siew Chien Ng, Stephen Hanauer, Suhang Verma, Usha Dutta, Vandana Midha, Varun Mehta, Vineet Ahuja, Ajit Sood
Intest Res.
2022;20(1):11-30.
Published online April 15, 2021
DOI:
https://doi.org/10.5217/ir.2020.00155
Cited By 29
Full text
PubReader
ePub
PDF
Management of inflammatory bowel disease in the COVID-19 era
Kyeong Ok Kim, Byung Ik Jang
Intest Res.
2022;20(1):3-10.
Published online February 3, 2021
DOI:
https://doi.org/10.5217/ir.2020.00156
Cited By 16
Full text
PubReader
ePub
PDF
Which biologic agents increase perioperative complications in patients with inflammatory bowel disease?
Jihye Park
Intest Res.
2022;20(1):1-2.
Published online January 26, 2022
DOI:
https://doi.org/10.5217/ir.2021.00170
Cited By 1
Full text
PubReader
ePub
PDF
Miscellaneous
An elderly woman with severe enteritis mimicking infectious enteritis
Kazunori Nagashima, Takashi Kato, Taichi Kimura, Kazuma Kishi, Urara Baba
Intest Res.
2021;19(4):482-484.
Published online July 3, 2020
DOI:
https://doi.org/10.5217/ir.2020.00038
Full text
PubReader
ePub
PDF
IBD
Anti-inflammatory properties of
Escherichia coli
Nissle 1917 in a murine colitis model
Jihye Park, Da Hye Kim, Soochan Kim, Hyun Woo Ma, I Seul Park, Mijeong Son, Ji Hyung Kim, Yoojin Shin, Seung Won Kim, Jae Hee Cheon
Intest Res.
2021;19(4):478-481.
Published online October 26, 2021
DOI:
https://doi.org/10.5217/ir.2021.00121
Cited By 2
Full text
PubReader
ePub
PDF
Pediatric Crohn’s disease with severe morbidity manifested by gastric outlet obstruction: two cases report and review of the literature
Eun Sil Kim, Ji Hyung Park, Yon Ho Choe, Mi Jin Kim
Intest Res.
2021;19(4):472-477.
Published online October 29, 2020
DOI:
https://doi.org/10.5217/ir.2020.00072
Cited By 1
Full text
PubReader
ePub
PDF
Miscellaneous
Hydroxyurea associated ileocecal valve ulcer: evidence for causality
Thevaraajan Jayaraman, Ruveena Bhavani Rajaram, Gin Gin Gan, Ida Hilmi
Intest Res.
2021;19(4):468-471.
Published online December 1, 2020
DOI:
https://doi.org/10.5217/ir.2020.00099
Cited By 1
Full text
PubReader
ePub
PDF
Inflammatory Bowel Diseases
Is there a correlation between infliximab trough levels and the development of adverse events in patients with inflammatory bowel disease?
Eirini Theodoraki, Eleni Orfanoudaki, Kalliopi Foteinogiannopoulou, Evangelia Legaki, Maria Gazouli, Ioannis E. Koutroubakis
Intest Res.
2021;19(4):461-467.
Published online August 18, 2020
DOI:
https://doi.org/10.5217/ir.2020.00042
Cited By 4
Full text
PubReader
ePub
PDF
Efficacy and safety of a new vedolizumab subcutaneous formulation in Japanese patients with moderately to severely active ulcerative colitis
Taku Kobayashi, Hiroaki Ito, Toshifumi Ashida, Tadashi Yokoyama, Masakazu Nagahori, Tomoki Inaba, Mitsuhiro Shikamura, Takayoshi Yamaguchi, Tetsuharu Hori, Philippe Pinton, Mamoru Watanabe, Toshifumi Hibi
Intest Res.
2021;19(4):448-460.
Published online August 18, 2020
DOI:
https://doi.org/10.5217/ir.2020.00026
Cited By 10
Full text
PubReader
ePub
PDF
Supplementary Material
High mucosal cytomegalovirus DNA helps predict adverse short-term outcome in acute severe ulcerative colitis
Saransh Jain, Divya Namdeo, Pabitra Sahu, Saurabh Kedia, Peush Sahni, Prasenjit Das, Raju Sharma, Vipin Gupta, Govind Makharia, Lalit Dar, Simon PL Travis, Vineet Ahuja
Intest Res.
2021;19(4):438-447.
Published online November 6, 2020
DOI:
https://doi.org/10.5217/ir.2020.00055
Cited By 7
Full text
PubReader
ePub
PDF
Supplementary Material
1
2
3
4
5
6
7
8
9
10
Journal Impact Factor 4.9
ABOUT
Aims and scope
About the journal
About the society
Editorial board
Managing team
Best practice
Metrics
Contact us
ARTICLE & TOPICS
Article Category
Editorial
Review
Original article
Case report
Images of the issue
Letters to the editor
Others
Browse all articles >
TOPICS
IBD
Infection
Tumor
Endoscopy
Microbiota
Miscellaneous
Functional disorder
Browse all articles >
BROWSE ARTICLES
Current issue
All issues
Ahead-of print
Most view
Most download
Most cited
Hot topic
Funded articles
Search
Author index
EDITORIAL POLICY
Research & publication ethics
Peer review policy
Copyright & license
Others
- Data sharing policy
- Archiving policy
- Preprint policy
- Advertising policy
- CrossMark policy
AUTHOR INFORMATION
FOR AUTHORS
Instructions to authors
Review flow
Article processing charge
Author’s checklist
Copyright transfer agreement
E-submission
FOR REVIEWERS
Instructions to reviewers
How to become a reviewer?